It does not, and the FDA's reasoning here is worth taking seriously
Their AI doctor draws from the latest medical research and personalizes information based on your health history
What this means for you right now: BPC-157 and TB-500 are currently available through licensed compounding pharmacies under clinician supervision Thymosin Alpha-1 has a longer regulatory history and a more established compounding track record Sourcing from unregulated vendors carries real safety risks contamination, misdosing, and no quality control We've covered the full regulatory picture in detail here: PCAC Peptide Review 2026: What the July Advisory Panel Decision Means for BPC-157, TB-500, and Thymosin Alpha-1 What a Clinician-Supervised Long COVID Peptide Protocol Looks Like A responsible protocol starts with assessment not assumption
A: We work with a number of logistics companies to ensure fast and safe delivery of goods around the world
Long-Term Health Consequences : Prolonged use may carry risks that have not been studied, including impacts on hormones or growth factors
BPC-175 + TB-500 is a dual-peptide capsule blend formulated for in vitro research into recovery-related signalling pathways